{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T01:39:53Z","timestamp":1794447593995,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100014034","name":"RHEUMASEARCH Foundation for Research in Rheumatology","doi-asserted-by":"publisher","award":["016"],"award-info":[{"award-number":["016"]}],"id":[{"id":"10.13039\/501100014034","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ard.2026.02.003","type":"journal-article","created":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T20:28:48Z","timestamp":1772742528000},"page":"1140-1155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment"],"prefix":"10.1016","volume":"85","author":[{"given":"Sofia","family":"Papanikolaou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgenia","family":"Emmanouilidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Adamichou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Kalogiannaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dionysios","family":"Nikolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Micaela","family":"Fredi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Marie","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Tani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noemin","family":"Kapsala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Argiro","family":"Repa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Malissovas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panagiotis","family":"Garantziotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nestor","family":"Avgoustidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra","family":"Nikoleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggelos","family":"Banos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giannis","family":"Vatsellas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prodromos","family":"Sidiropoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Konstantopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Boumpas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward M","family":"Vital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Andreoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mosca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu\u00eds","family":"In\u00eas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoforos","family":"Nikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5299-1406","authenticated-orcid":false,"given":"George","family":"Bertsias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2026.02.003_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.890522","article-title":"Understanding the concept of pre-clinical autoimmunity: prediction and prevention of systemic lupus erythematosus: identifying risk factors and developing strategies against disease development","volume":"13","author":"Choi","year":"2022","journal-title":"Front Immunol"},{"issue":"16","key":"10.1016\/j.ard.2026.02.003_bib0002","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0003","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar3258","article-title":"Autoantibodies predate the onset of systemic lupus erythematosus in northern Sweden","volume":"13","author":"Eriksson","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ard.2026.02.003_bib0004","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jaut.2016.06.001","article-title":"Dysregulation of innate and adaptive serum mediators precedes systemic lupus erythematosus classification and improves prognostic accuracy of autoantibodies","volume":"74","author":"Lu","year":"2016","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.ard.2026.02.003_bib0005","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1136\/annrheumdis-2015-208140","article-title":"Altered type II interferon precedes autoantibody accrual and elevated type I interferon activity prior to systemic lupus erythematosus classification","volume":"75","author":"Munroe","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.ard.2026.02.003_bib0006","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1002\/art.39706","article-title":"Autoantibody-positive healthy individuals display unique immune profiles that may regulate autoimmunity","volume":"68","author":"Slight-Webb","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.ard.2026.02.003_bib0007","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1136\/ard-2023-225349","article-title":"Blood RNA-sequencing across the continuum of ANA-positive autoimmunity reveals insights into initiating immunopathology","volume":"83","author":"Carter","year":"2024","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2026.02.003_bib0008","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/annrheumdis-2018-214379","article-title":"Combined genetic and transcriptome analysis of patients with SLE: distinct, targetable signatures for susceptibility and severity","volume":"78","author":"Panousis","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0009","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-73654-4","article-title":"Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus","volume":"10","author":"Ntasis","year":"2020","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1016\/j.ard.2026.02.003_bib0010","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1136\/annrheumdis-2022-eular.3965","article-title":"POS0768 presence of anti-Ro\/SSA autoantibodies, hypocomplementemia and photosensitivity indicate individuals with connective tissue disease features who are at increased risk for transition to systemic lupus erythematosus","volume":"81","author":"Emmanouilidou","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.ard.2026.02.003_bib0011","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.ard.2026.02.003_bib0012","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1136\/annrheumdis-2018-214819","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology classification criteria for systemic lupus erythematosus","volume":"78","author":"Aringer","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.ard.2026.02.003_bib0013","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"issue":"7","key":"10.1016\/j.ard.2026.02.003_bib0014","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12859-018-2053-1","article-title":"CEMiTool: a bioconductor package for performing comprehensive modular co-expression analyses","volume":"19","author":"Russo","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.ard.2026.02.003_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2020.103975","article-title":"Advantages of CEMiTool for gene co-expression analysis of RNA-seq data","volume":"125","author":"Cheng","year":"2020","journal-title":"Comput Biol Med"},{"issue":"7","key":"10.1016\/j.ard.2026.02.003_bib0017","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/s41587-019-0114-2","article-title":"Determining cell type abundance and expression from bulk tissues with digital cytometry","volume":"37","author":"Newman","year":"2019","journal-title":"Nat Biotechnol"},{"issue":"5","key":"10.1016\/j.ard.2026.02.003_bib0018","doi-asserted-by":"crossref","first-page":"bbac332","DOI":"10.1093\/bib\/bbac332","article-title":"Scoring personalized molecular portraits identify systemic lupus erythematosus subtypes and predict individualized drug responses, symptomatology and disease progression","volume":"23","author":"Toro-Dominguez","year":"2022","journal-title":"Brief Bioinform"},{"issue":"2","key":"10.1016\/j.ard.2026.02.003_bib0019","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/ard-2024-226051","article-title":"Molecular basis for the disease-modifying effects of belimumab in systemic lupus erythematosus and molecular predictors of early response: blood transcriptome analysis implicates the innate immunity and DNA damage response pathways","volume":"84","author":"Moysidou","year":"2025","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.ard.2026.02.003_bib0020","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1136\/ard-2023-225445","article-title":"Type I interferon blockade with anifrolumab in patients with systemic lupus erythematosus modulates key immunopathological pathways in a gene expression and proteomic analysis of two phase 3 trials","volume":"83","author":"Baker","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ard.2026.02.003_bib0021","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. An algorithm for fast preranked gene set enrichment analysis using cumulative statistic calculation. bioRxiv. 2021:060012."},{"key":"10.1016\/j.ard.2026.02.003_bib0022","doi-asserted-by":"crossref","DOI":"10.1038\/npjsba.2016.15","article-title":"L1000CDS(2): LINCS L1000 characteristic direction signatures search engine","volume":"2","author":"Duan","year":"2016","journal-title":"NPJ Syst Biol Appl."},{"issue":"6","key":"10.1016\/j.ard.2026.02.003_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2017.10.049","article-title":"A next generation connectivity map: L1000 platform and the first 1,000,000 profiles","volume":"171","author":"Subramanian","year":"2017","journal-title":"Cell"},{"issue":"9","key":"10.1016\/j.ard.2026.02.003_bib0024","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.ard.2026.02.003_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.06.004","article-title":"Preclinical and early systemic lupus erythematosus","volume":"33","author":"Gatto","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"12","key":"10.1016\/j.ard.2026.02.003_bib0026","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/acr.23201","article-title":"Clinical and serologic features in patients with incomplete lupus classification versus systemic lupus erythematosus patients and controls","volume":"69","author":"Aberle","year":"2017","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"9","key":"10.1016\/j.ard.2026.02.003_bib0027","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1093\/rheumatology\/keaa114","article-title":"Proportions of B-cell subsets are altered in incomplete systemic lupus erythematosus and correlate with interferon score and IgG levels","volume":"59","author":"Henning","year":"2020","journal-title":"Rheumatology (Oxford)"},{"issue":"8","key":"10.1016\/j.ard.2026.02.003_bib0028","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1093\/intimm\/dxn056","article-title":"Progressive divergent shifts in natural and induced T-regulatory cells signify the transition from undifferentiated to definitive connective tissue disease","volume":"20","author":"Szodoray","year":"2008","journal-title":"Int Immunol"},{"issue":"2","key":"10.1016\/j.ard.2026.02.003_bib0029","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003967","article-title":"Disease evolution and organ damage accrual in patients with stable UCTD: a long-term monocentric inception cohort","volume":"10","author":"Tani","year":"2024","journal-title":"RMD Open"},{"issue":"10","key":"10.1016\/j.ard.2026.02.003_bib0030","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1136\/annrheumdis-2018-213386","article-title":"Prediction of autoimmune connective tissue disease in an at-risk cohort: prognostic value of a novel two-score system for interferon status","volume":"77","author":"Md Yusof","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.ard.2026.02.003_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105381","article-title":"Persistent low complement levels and increased interferon gene expression are predictive for disease progression in patients with incomplete systemic lupus erythematosus","volume":"89","author":"Lambers","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0032","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13075-023-02997-w","article-title":"Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA(+) individuals without a systemic autoimmune rheumatic disease diagnosis","volume":"25","author":"Kim","year":"2023","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0033","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000270","article-title":"Interferon pathway in SLE: one key to unlocking the mystery of the disease","volume":"6","author":"Ronnblom","year":"2019","journal-title":"Lupus Sci Med"},{"issue":"10","key":"10.1016\/j.ard.2026.02.003_bib0034","first-page":"575","article-title":"Emerging concepts of type I interferons in SLE pathogenesis and therapy","volume":"18","author":"Psarras","year":"2022","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.ard.2026.02.003_bib0035","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.immuni.2024.03.004","article-title":"Decoding Toll-like receptors: recent insights and perspectives in innate immunity","volume":"57","author":"Kawai","year":"2024","journal-title":"Immunity"},{"key":"10.1016\/j.ard.2026.02.003_bib0036","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217614","article-title":"Targeting p53 for immune modulation: Exploring its functions in tumor immunity and inflammation","volume":"617","author":"Wu","year":"2025","journal-title":"Cancer Lett"},{"issue":"6","key":"10.1016\/j.ard.2026.02.003_bib0037","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1002\/art.38628","article-title":"Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures","volume":"66","author":"Chiche","year":"2014","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0038","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13075-021-02414-0","article-title":"The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus","volume":"23","author":"Mai","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0039","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000625","article-title":"Type 1 interferon status in systemic lupus erythematosus: a longitudinal analysis","volume":"9","author":"Northcott","year":"2022","journal-title":"Lupus Sci Med"},{"issue":"9","key":"10.1016\/j.ard.2026.02.003_bib0040","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1002\/art.22044","article-title":"Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus","volume":"54","author":"Feng","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.ard.2026.02.003_bib0041","article-title":"Uncoupling interferons and the interferon signature explains clinical and transcriptional subsets in SLE","volume":"5","author":"Gomez-Banuelos","year":"2024","journal-title":"Cell Rep Med"},{"issue":"6","key":"10.1016\/j.ard.2026.02.003_bib0042","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1136\/annrheumdis-2021-221835","article-title":"Serum interferon-alpha levels and IFN type I-stimulated genes score perform equally to assess systemic lupus erythematosus disease activity","volume":"81","author":"Chasset","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"18","key":"10.1016\/j.ard.2026.02.003_bib0043","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.07.021","article-title":"Distinct transcriptome architectures underlying lupus establishment and exacerbation","volume":"185","author":"Nakano","year":"2022","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.ard.2026.02.003_bib0044","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1038\/s41467-021-22312-y","article-title":"Type I interferons affect the metabolic fitness of CD8(+) T cells from patients with systemic lupus erythematosus","volume":"12","author":"Buang","year":"2021","journal-title":"Nat Commun"},{"issue":"6","key":"10.1016\/j.ard.2026.02.003_bib0045","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1136\/annrheumdis-2021-221464","article-title":"Immune cell multiomics analysis reveals contribution of oxidative phosphorylation to B-cell functions and organ damage of lupus","volume":"81","author":"Takeshima","year":"2022","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.ard.2026.02.003_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.09.001","article-title":"IFNalpha impairs autophagic degradation of mtDNA promoting autoreactivity of SLE monocytes in a STING-dependent fashion","volume":"25","author":"Gkirtzimanaki","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.ard.2026.02.003_bib0047","first-page":"1900","article-title":"Identifying predictive serum soluble mediators signatures specific to ANA+ at risk of SLE individuals with next generation proteomics","volume":"76","author":"Bylinska","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2026.02.003_bib0048","first-page":"1834","article-title":"Single-cell multi-omic evaluation of differences in immune cell populations in progression toward systemic lupus erythematosus","volume":"75","author":"Bylinska","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.ard.2026.02.003_bib0049","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2025-001753","article-title":"Dysregulated soluble immune mediators and lupus-associated autoantibody specificities inform the development of immune indexes that characterise classified SLE transition and SLE disease activity","volume":"12","author":"Munroe","year":"2025","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.ard.2026.02.003_bib0050","first-page":"5028","article-title":"Characterisation of immunometabolic reprogramming at the single cell level in patients with systemic lupus erythematosus and preclinical autoimmunity","volume":"77","author":"Psarras","year":"2025","journal-title":"Arthritis Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726000786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496726000786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T14:14:51Z","timestamp":1780323291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496726000786"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S0003496726000786"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.02.003","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Progression from at-risk state to clinical and severe systemic lupus erythematosus involves molecular dysregulations potentially reversible by biologics: implications for early diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}